About EPIT

Founded: 2005
Employees: 44
CEO: Radan Hashimshony
WebsiteView website: epitomeemedical.com

Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.

Recent EPIT News & Updates

New Risk • Jan 20

New major risk - Share price stability

The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 7.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.4% average weekly change). High level of non-cash earnings (198% accrual ratio). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (₪290.3m market cap, or US$91.9m).

Recent updates

No updates

Epitomee Medical Ltd Stock Price

EPIT Share Price Performance

EPIT Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Epitomee Medical Ltd Key Details

About EPIT

Recent EPIT News & Updates

We Think Epitomee Medical (TLV:EPIT) Can Afford To Drive Business Growth

New minor risk - Financial data availability

New major risk - Share price stability

Recent updates

Epitomee Medical Ltd Competitors

SofWave Medical

Bait Bakfar

Ilex Medical

Novolog (Pharm-Up 1966)